drug protocol number

D6972C00002

drug sponsor

Astrazeneca

drug study

Baxdrostat

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh), King Abdulaziz Hospital NG (Al Ahsa), King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase